English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Viral hepatitis has been regarded as one of the major public health concerns that require an immediate and comprehensive response for its prevention and control1,2. In-fact, viral hepatitis accounted for more than 1.3 million deaths, predominantly due to chronic liver disease and liver malignancy in the year 2015, of which more than 95% are due to either hepatitis B virus (HBV) or hepatitis C virus (HCV) infection1. In addition, in excess of 250 million and 70 million people are living with chronic hepatitis B and C infection globally, with hepatitis B is more common in the African region, while hepatitis C is predominant in the Eastern Mediterranean region1.

Küresel viral hepatit problemiyle mücadelede halk sağlığı yanıtının güçlendirilmesi